ERBB2 and breast cancer: Cui et al. [33] observed no significant differences in survival between PTK7-high and PTK7-low patients across luminal A, luminal B, or HER2-positive BC subtypes but found significantly worse RFS in TNBC patients with high PTK7 expression.